tiprankstipranks
Trending News
More News >
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Cash flow

Compare
0 Followers

Hansa Biopharma AB Cash Flow

SE:HNSA's free cash flow for Q1 2025 was kr-152.50M. For the 2025 fiscal year, SE:HNSA's free cash flow was decreased by kr21.90M and operating cash flow was kr-151.87M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -733.92Mkr -755.65Mkr -502.73Mkr -481.17Mkr -290.27M
Investing Cash Flow
kr -116.00Kkr -284.00Kkr 229.31Mkr -2.40Mkr 182.53M
Financing Cash Flow
kr 405.84Mkr -7.54Mkr 1.12Bkr -4.86Mkr 1.07B
End Cash Position
kr 405.28Mkr 732.06Mkr 1.50Bkr 651.34Mkr 1.14B
Free Cash Flow
kr -734.04Mkr -755.94Mkr -506.06Mkr -483.57Mkr -290.57M
Currency in SEK

Hansa Biopharma AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis